These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6818606)

  • 1. Differential efficacy of L-deprenyl, a selective MAO type-B inhibitor, in endogenous and nonendogenous depression.
    Mann JJ; Frances A; Peselow ED; Gershon S
    Psychopharmacol Bull; 1982 Oct; 18(4):182-4. PubMed ID: 6818606
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative efficacy of l-deprenyl, a selective monoamine oxidase type B inhibitor, in endogenous and nonendogenous depression.
    Mann JJ; Frances A; Kaplan RD; Kocsis J; Peselow ED; Gershon S
    J Clin Psychopharmacol; 1982 Feb; 2(1):54-7. PubMed ID: 6802883
    [No Abstract]   [Full Text] [Related]  

  • 3. A placebo-controlled trial of L-deprenyl in atypical depression.
    McGrath PJ; Stewart JW; Harrison W; Wager S; Nunes EN; Quitkin FM
    Psychopharmacol Bull; 1989; 25(1):63-7. PubMed ID: 2505303
    [No Abstract]   [Full Text] [Related]  

  • 4. A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor.
    Mann JJ; Aarons SF; Wilner PJ; Keilp JG; Sweeney JA; Pearlstein T; Frances AJ; Kocsis JH; Brown RP
    Arch Gen Psychiatry; 1989 Jan; 46(1):45-50. PubMed ID: 2491941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. l-Deprenyl in atypical depressives.
    Quitkin FM; Liebowitz MR; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Markowitz J; Davies SO
    Arch Gen Psychiatry; 1984 Aug; 41(8):777-81. PubMed ID: 6430257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAO-B-Inhibitor selegiline (R-(-)-deprenyl). A new therapeutic concept in the treatment of Parkinson's disease. Proceedings of the international symposium. Berlin, January 23-25, 1987.
    J Neural Transm Suppl; 1987; 25():1-197. PubMed ID: 3123595
    [No Abstract]   [Full Text] [Related]  

  • 7. L-deprenyl plus L-phenylalanine in the treatment of depression.
    Birkmayer W; Riederer P; Linauer W; Knoll J
    J Neural Transm; 1984; 59(1):81-7. PubMed ID: 6425455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of deprenyl, a specific inhibitor of MAOB.
    Psychopharmacol Bull; 1983; 19(3):328-42. PubMed ID: 6314420
    [No Abstract]   [Full Text] [Related]  

  • 9. Biochemical effects of L-deprenyl in atypical depressives.
    Liebowitz MR; Karoum F; Quitkin FM; Davies SO; Schwartz D; Levitt M; Linnoila M
    Biol Psychiatry; 1985 May; 20(5):558-65. PubMed ID: 3921065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation.
    Mendlewicz J; Youdim MB
    Br J Psychiatry; 1983 May; 142():508-11. PubMed ID: 6409196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
    Simpson GM; Frederickson E; Palmer R; Pi E; Sloane RB; White K
    Biol Psychiatry; 1985 Jun; 20(6):684-7. PubMed ID: 3922441
    [No Abstract]   [Full Text] [Related]  

  • 12. L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression.
    Mann J; Gershon S
    Life Sci; 1980 Mar; 26(11):877-82. PubMed ID: 6768943
    [No Abstract]   [Full Text] [Related]  

  • 13. A possible L-deprenyl induced hypertensive reaction.
    McGrath PJ; Stewart JW; Quitkin FM
    J Clin Psychopharmacol; 1989 Aug; 9(4):310-1. PubMed ID: 2504782
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO "type B" inhibitor.
    Mendlewicz J; Youdim MB
    J Neural Transm; 1978; 43(3-4):279-86. PubMed ID: 745020
    [No Abstract]   [Full Text] [Related]  

  • 15. Rationale for (-)deprenyl (selegiline) medication in Parkinson's disease and in prevention of age-related nigral changes.
    Knoll J
    Biomed Pharmacother; 1995; 49(4):187-95. PubMed ID: 7669938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of monoamine oxidase type A, but not type B, is an effective means of inducing anticonvulsant activity in the kindling model of epilepsy.
    Löscher W; Lehmann H; Teschendorf HJ; Traut M; Gross G
    J Pharmacol Exp Ther; 1999 Mar; 288(3):984-92. PubMed ID: 10027835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant potentiation of 5-hydroxytryptophan by L-deprenil in affective illness.
    Mendlewicz J; Youdim MB
    J Affect Disord; 1980 Jun; 2(2):137-46. PubMed ID: 6448885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect?
    Mendis N; Pare CM; Sandler M; Glover V; Stern GM
    Psychopharmacology (Berl); 1981; 73(1):87-90. PubMed ID: 6785797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of extra-puerperal galactorrhea with the MAO-B inhibitor selegiline].
    Sas M; Godó G; Koleszár G
    Orv Hetil; 1986 Jun; 127(25):1507-8, 1511. PubMed ID: 3088511
    [No Abstract]   [Full Text] [Related]  

  • 20. [History of deprenyl--the first selective inhibitor of monoamine oxidase type B].
    Knoll J
    Vopr Med Khim; 1997; 43(6):482-93. PubMed ID: 9503565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.